TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Cancer Incidence Rates For Recent Years Too Optimistic, NCI Researchers Find October 25, 2002
TCL Archive In Brief: Yale Names DeVita Center Director; Canellos, Anrman Lead ASCO; Bresnick To Head AACR June 4, 1993
TCL Archive New Mexico CBCCP Charges Contracts Terminated for “Mundane Political, Economic” Factors April 25, 1980
